Modifications

=== [[GcMAF]] ===

=== [[GcMAF]] ===

[[image:Gcmaf-immunology-conference.png|David Noakes directeur de Immuno Biotech entouré de son réseau et de ses soutiens à la 1re conférence [[Gc-MAF]] à Frankfurt (Francfort) du 19 au 21 avril 2013.<br>De gauche à droite, Assis devant : Dr Kenny de Meirleir, Dr [[Emar Vogelaar]], [[David Noakes]] [directeur d'Immuno Biotech Ltd à Guernesey], Dr [[Dario Siniscalco|Siniscalco]] et Dr Jeffrey Bradstreet.<br>2ème rang Joanne Spinks, Joan Crawford, Dr [[Hendrik Treugut]], Dr Blesius, Dr Lughten, Dr Mikael Nordfors<br>3ème rang, debouts : Professor [[Marco Ruggiero]] MD, Dr Gabriele Morucci PhD, Dr Rod Smith PhD, Dr Steven Hoffmann<br>Source <ref>http://www.gcmafconference.org/april/index.php?option=com_content&view=article&id=33&Itemid=181 Photo d'ensemble des speakers sur le site de First Immune. On trouve y également, en cliquant dans la colonne de gauche, la présentation des divers orateurs</ref>|450px|thumb]]

[[image:Gcmaf-immunology-conference.png|David Noakes directeur de Immuno Biotech entouré de son réseau et de ses soutiens à la 1re conférence [[Gc-MAF]] à Frankfurt (Francfort) du 19 au 21 avril 2013.<br>De gauche à droite, Assis devant : Dr Kenny de Meirleir, Dr [[Emar Vogelaar]], [[David Noakes]] [directeur d'Immuno Biotech Ltd à Guernesey], Dr [[Dario Siniscalco|Siniscalco]] et Dr Jeffrey Bradstreet.<br>2ème rang Joanne Spinks, Joan Crawford, Dr [[Hendrik Treugut]], Dr Blesius, Dr Lughten, Dr Mikael Nordfors<br>3ème rang, debouts : Professor [[Marco Ruggiero]] MD, Dr Gabriele Morucci PhD, Dr Rod Smith PhD, Dr Steven Hoffmann<br>Source <ref>http://www.gcmafconference.org/april/index.php?option=com_content&view=article&id=33&Itemid=181 Photo d'ensemble des speakers sur le site de First Immune. On trouve y également, en cliquant dans la colonne de gauche, la présentation des divers orateurs</ref>|500px|thumb]]

D'autres traitements que Bradstreet utilisaient fréquemment sur ​​les enfants autistes comprennaient le [[GcMAF]] (Gc protein-derived Macrophage Activating Factor), avec lequel il prétendait avoir traité 600 enfants<ref>http://www.prweb.com/releases/2012/9/prweb9857174.htm Publié le 8 septembre 2012 :<br>Dr Bradstreet has treated 600 children with [[GcMAF]] in the USA and will publicise some of his results at the Treating Autism Conference on September 9th and in a paper being published afterwards.<br>Dr Bradstreet tested hundreds of children for Nagalase and found over 80% had high levels. High Nagalase levels indicates the presence of viruses and a severely weakened immune system. 46 research papers by 107 eminent scientists prove [[GcMAF]] restores the immune system, and reduces nagalase down to healthy levels.<br>Dr [[Nicola Antonucci]] in Italy treated 94 children with autism, 83 had significant improvements, and he believes [[GcMAF]] to be the most effective treatment of autism. It is essential to ensure the [[GcMAF]] has been tested with live cell (eg macrophage cell) assays, or it may not be active. [...] Report on Autism treated with [[GcMAF]] in Italy by Dr. [[Nicola Antonucci|Antonucci]] and Dr. [[Dario Siniscalco|Siniscalco]] [...]</ref>.

D'autres traitements que Bradstreet utilisaient fréquemment sur ​​les enfants autistes comprennaient le [[GcMAF]] (Gc protein-derived Macrophage Activating Factor), avec lequel il prétendait avoir traité 600 enfants<ref>http://www.prweb.com/releases/2012/9/prweb9857174.htm Publié le 8 septembre 2012 :<br>Dr Bradstreet has treated 600 children with [[GcMAF]] in the USA and will publicise some of his results at the Treating Autism Conference on September 9th and in a paper being published afterwards.<br>Dr Bradstreet tested hundreds of children for Nagalase and found over 80% had high levels. High Nagalase levels indicates the presence of viruses and a severely weakened immune system. 46 research papers by 107 eminent scientists prove [[GcMAF]] restores the immune system, and reduces nagalase down to healthy levels.<br>Dr [[Nicola Antonucci]] in Italy treated 94 children with autism, 83 had significant improvements, and he believes [[GcMAF]] to be the most effective treatment of autism. It is essential to ensure the [[GcMAF]] has been tested with live cell (eg macrophage cell) assays, or it may not be active. [...] Report on Autism treated with [[GcMAF]] in Italy by Dr. [[Nicola Antonucci|Antonucci]] and Dr. [[Dario Siniscalco|Siniscalco]] [...]</ref>.